Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGusbourne Regulatory News (GUS)

  • There is currently no data for GUS

Director/PDMR Shareholding

20 Jun 2006 14:44

GUS PLC20 June 2006 GUS plc ("THE COMPANY") DIRECTORS' INTERESTS IN CONNECTION WITH THE GUS PLC PERFORMANCE SHARE PLAN In June 2003 the Company made awards under its Performance Share Plan todirectors with such awards taking the form of a deferred right to acquire sharesat no cost to the participant. The vesting of such awards is subject toperformance conditions and the conditions in respect of this award have now beensatisfied. Accordingly, on 19 June 2006, the following transactions in theCompany's ordinary shares of 29 3/43p each took place: Name of Plan shares Plan shares Plan shares Number ofdirector released sold after retained Ordinary release * shares now held John Peace 103,626 42,572 61,054 521,699 Terry Duddy 85,862 35,275 50,587 357,420 Don Robert 26,619 9,336 17,283 283,641 David Tyler 62,176 25,544 36,632 324,357 * The sales of shares took place on the London Stock Exchange at a price of928.8194p per share and were made to satisfy the tax liabilities falling due onthe vesting of these awards. Following this notification, the number of Ordinary shares in the Company heldby John Peace represents 0.06% of the Company's issued share capital (excludingTreasury shares). The holdings for Terry Duddy, Don Robert and David Tylerrepresent 0.04%, 0.03% and 0.04% respectively. Notifications of these transactions were received by the Company on 20 June 2006and were made in accordance with DR 3.1.4R(1)(b). This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
27th Jun 20237:00 amRNSBoard Change
7th Jun 20237:00 amRNSFinal Results
21st Mar 20237:00 amRNSDirectorate Change
14th Feb 202312:12 pmRNSAIM Rule 17 Notification
31st Jan 20237:00 amRNSTrading Update
16th Jan 20231:32 pmRNSIssue of Equity
20th Dec 20227:00 amRNSGrant of Share Options
16th Dec 202210:30 amRNSIssue of Equity
14th Dec 20227:00 amRNSExtension of the final exercise date of Warrants
27th Oct 20227:00 amRNSHarvest Report
4th Oct 20221:51 pmRNSIssue of Equity
29th Sep 20227:00 amRNSInterim results to 30 June 2022
6th Sep 20227:00 amRNSChange of Adviser
22nd Aug 20227:00 amRNSDirectorate Change
15th Aug 20227:00 amRNSTrading Update, Refinancing & Land Purchase
30th Jun 20222:00 pmRNSResult of AGM
6th Jun 20227:00 amRNSFinal Results
3rd May 202210:15 amRNSIssue of Equity
29th Mar 202212:10 pmRNSIssue of Equity
2nd Mar 20229:30 amRNSIssue of Equity
10th Feb 20227:00 amRNSTrading Update
17th Dec 20217:00 amRNSCompletion of Warrant Issue
15th Dec 20213:50 pmRNSFurther re Issue of Warrants
15th Dec 20217:00 amRNSResult of Open Offer and Issue of Warrants
22nd Nov 20217:00 amRNSLaunch of Open Offer and Posting of Circular
2nd Nov 20214:34 pmRNSDirector/PDMR Shareholding
1st Nov 20217:00 amRNSResult of Warrant Exercise and Debt Conversion
18th Oct 20214:30 pmRNSApplication for Admission
18th Oct 20212:10 pmRNSResult of ABB
18th Oct 20217:01 amRNSPlacing and Subscription
18th Oct 20217:00 amRNSFunding Update
30th Sep 20217:00 amRNSInterim Results to 30 June 2021
10th Aug 20217:38 amRNSIssue of Equity
23rd Jul 20217:00 amRNSDirector/PDMR Shareholding
22nd Jul 20217:00 amRNSTrading and Capital Structure Update
19th Jul 20211:00 pmRNSIssue of Equity
5th Jul 20217:00 amRNSPublication of Capital Markets Day Recording
30th Jun 202111:45 amRNSResult of AGM
14th Jun 20212:30 pmRNSExercise of Warrants
7th Jun 20217:00 amRNSFinal Results
1st Feb 20217:00 amRNSTrading Update
8th Dec 20204:40 pmRNSSecond Price Monitoring Extn
8th Dec 20204:35 pmRNSPrice Monitoring Extension
4th Dec 20207:00 amRNSAppointment of Joint Broker
21st Sep 20208:00 amRNSHalf-year Report
2nd Sep 20204:15 pmRNSDirectorate Change
23rd Jul 202011:28 amRNSResult of AGM
23rd Jul 202010:48 amRNSDirector/PDMR Shareholding
25th Jun 20207:00 amRNSFinal Results
24th Jun 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.